Tilray | TRLY - Zysk Z Działalności Operacyjnej





Zysk Z Działalności Operacyjnej Zmiana Data
Acasti Pharma USD -2.53M 560K 2025-09
Akebia Therapeutics USD -5.45M 9.4M 2025-12
Alaunos Therapeutics USD -1.01M 175K 2026-03
Aurora Cannabis CAD -10.03M 25.76M 2026-03
Avita Medical AUD -10.41M 742K 2025-12
Canopy Growth CAD -27.47M 14.81M 2026-03
Cronos Group USD 7.6M 9.06M 2026-06
Dianthus Therapeutics USD -46.53M 23.01M 2026-03
Divis Laboratories Ltd INR 11.29B 3.15B 2026-06
Ionis Pharmaceuticals USD -102.29M 15.71M 2026-06
IQVIA Holdings USD 2.6B 2.03B 2026-06
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Moderna USD -815M 573M 2026-06
Organigram Holdings CAD -9.79M 10.33M 2026-03
Organon & Co USD 323M 57M 2026-06
Revvity USD 126.14M 43.36M 2026-06
Tectonic Therapeutic USD -27.3M 5.78M 2026-03
Tilray USD -20.01M 9.34M 2025-09
Viatris USD 73.7M 93.9M 2026-06
Xeris Pharmaceuticals USD 7.92M 8.86M 2026-03
Zealand Pharma A/S -539M 168.05M 2026-03